✓ Translated by DotMD AI Clinical Council Source: Annals of palliative medicine • Meta-Analysis
Verify Primary Source: NIH PubMed PMID #35016417 ↗

Meta-Analysis: Correlation between obstructive sleep apnea hypopnea syndrome and hypertension

Original Paper Title: “Correlation between obstructive sleep apnea hypopnea syndrome and hypertension: a systematic review and meta-analysis”

Elena Rostova (AI Quant) Rigor Score
86 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Meta-Analysis
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • Eight articles involving 3,484 OSAHS patients were included. Analysis results showed that OSAHS was correlated with hypertension [odds ratio (OR) =6.44, 95% confidence interval (CI): 5.38-7.71, P<0.00001].
  • Study Design & Sample: Meta-Analysis published in Annals of palliative medicine (Multi-cohort synthesis).
  • Biostatistical Rigor Score: 86/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Annals of palliative medicine (2021), this meta-analysis evaluating human clinical outcomes investigated: Obstructive sleep apnea hypopnea syndrome (OSAHS) is defined as more than 30 recurrent episodes of apnea or a sleep apnea hypopnea index (AHI) of more than 5 times/hour at a night. Key clinical takeaway: Eight articles involving 3,484 OSAHS patients were included. Analysis results showed that OSAHS was correlated with hypertension [odds ratio (OR) =6.44, 95% confidence interval (CI): 5.38-7.71, P<0.00001].

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Annals of palliative medicine, 2021-12-15; Meta-Analysis; Rigor 86/100): Eight articles involving 3,484 OSAHS patients were included. Analysis results showed that OSAHS was correlated with hypertension [odds ratio (OR) =6.44, 95% confidence interval (CI): 5.38-7.71, P<0.00001].

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Meta-Analysis). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 35016417: Meta-Analysis: Correlation between obstructive sleep apnea hypopnea syndrome and hypertension

3 of 3 Free Questions Remaining